BiVACOR
Manufacturing · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
5432 Bolsa Ave Ste A & B, Huntington Bea...Website
www.bivacor.comRevenue
<$5 MillionIndustry
About BiVACOR
BiVACOR Org Chart
Is BiVACOR your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once BiVACOR has new funding data
Congratulate Masked Content for being promoted to Masked Content at BiVACOR
Check out if BiVACOR is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on BiVACOR recently announced quarterly report
BiVACOR, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when BiVACOR launches new products
Website visits: Recent activity has been detected on your website
Click to see if BiVACOR had a recent Job posting/layoffs
Check if BiVACOR has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Find VP level buyers at BiVACOR
Find more new buyers
Compare Similar Companies to BiVACOR
Compare insights from companies similar to BiVACOR, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
BiVACOR is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
BiVACOR is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about BiVACOR.
BiVACOR financials insights
Gather financial insights about BiVACOR, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
Grant
$3M
Series B
$19M
BiVACOR Tech Stack
A closer look at the technologies used by BiVACOR
Most Recent Scoops
BiVACOR News & Media
BiVACOR Total Artificial Heart Successfully Implanted in Five Patients as Part of FDA Early Feasibility Study; FDA Greenlights Expansion of the EFS
HUNTINGTON BEACH, Calif.--(BUSINESS WIRE)--The five-patient FDA Early Feasibility Study of BiVACOR Total Artificial Heart successfully bridges all to a donor heart transplant-EFS expanded to 15The Texas Heart Institute Implants BiVACOR® Total Artificial Heart
HOUSTON--(BUSINESS WIRE)--The Texas Heart Institute (THI) and BiVACOR®, a clinical-stage medical device company, announced today the successful first-in-human implantation of the BiVACOR Total Artificial Heart (TAH) as part of the U.S. Food and Drug Administration (FDA) Early Feasibility Study (EFS) on July 9, 2024. BiVACOR’s TAH is a titanium-constructed biventricular rotary blood pump with a single moving part that utilizes a magnetically levitated rotor that pumps the blood and replaces bothBiVACOR® Receives $13 Million to Support Clinical Trials for the Company’s Total Artificial Heart
GOLD COAST, Australia & HUNTINGTON BEACH, Calif.--(BUSINESS WIRE)--BiVACOR®, a clinical-stage medical device company, today announced $13 million (USD) awarded from the Australian Government’s Medical Research Future Fund (MRFF) grant through the Artificial Heart Frontiers Program (AHFP) to support BiVACOR’s Total Artificial Heart program and future product enhancements. Led by Monash University, the AHFP is comprised of a consortium of research centers in Australia in collaboration with BiVACOBiVACOR Names Veteran Medical Device Executive Jim Dillon as Chief Executive Officer
HUNTINGTON BEACH, Calif. & HOUSTON & GOLD COAST, Australia--(BUSINESS WIRE)--BiVACOR, Inc., a clinical-stage medical technology company developing a total artificial heart (TAH), today announced that Jim Dillon has been named chief executive officer and a member of its board of directors. Mr. Dillon is an experienced medical device executive whose career focus in heart failure has included developing cardiovascular therapies to enable native heart recovery, reducing the size of a patient’s myoc
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding BiVACOR
Founded in 2008 and headquartered in Houston, Texas, BiVACOR® is a medical device manufacturer. Our staff includes world-class engineers, medical specialists, and business executives, who are diligently working to advance this ground-breaking technology. Together, we have established a strong collaborative network that extends both nationally and i... Read More
